Takeda's Resubmission of EoE Drug For FDA Approval

FDA to review Takeda's resubmission of Budesonide oral suspension - NDA of TAK-721, offering new hope for Eosinophilic Oesophagitis (EoE) patients. What does this mean for the eosinophilic community? Read more

TSLP: A Pathway to Non-Invasive Blood Tests and Targeted Treatments

Learn how groundbreaking research on Thymic Stromal Lymphopoietin (TSLP) offers hope for more effective and less invasive diagnoses and treatments for eosinophilic diseases like EoE. Read more

Study: Weekly Doses of Dupilumab Are The Most Effective at Managing Eosinophilic Oesophagitis

Recent research shows weekly dupilumab outperforms bi-weekly treatments in managing Eosinophilic Oesophagitis (EoE) symptoms. Read more

Defining EoE Phenotypes Using Functional Lumen Imaging Probe (FLIP)

Explore new research findings on how FLIP panometry can be used to classify Eosinophilic Esophagitis (EoE) patients by disease severity. This innovative method could pave the way for personalised treatment plans, improving patient outcomes. Read more

Achalasia's Association with Eosinophilic Esophagitis and Other Allergic Disorders

Recent findings highlight an association between achalasia and Eosinophilic Esophagitis (EoE) in 6.5% of achalasia patients. Understanding this rare link may improve treatment options for both conditions, potentially benefiting those with EoE and achalasia. Read more

Removing Animal Milk Versus Removing Six Food Types as EoE Treatment

A recent multi-centred study reveals removing just animal milk as first-line diet therapy for EoE Eosinophilic Oesophagitis is equally effective in the 6-week trial. Read more

Improving Care in Eosinophil-Associated Diseases: A Charter

A Charter outlining the key rights and expectations for people living with eosinophil-associated diseases. It proposes four key principles that will patients should expect from the management of their conditions and set a basic standardisation of care. Read more

International Consensus Recommendations for EGID nomenclature

A publication in Clinical Gastroenterology and Hepatology has made an important step towards developing international consensus for EGID terminology. Read more

A New Study on Early Life Exposures as Risk Factors for Non-EoE EGIDs

A new study offers insight into the role of early life exposures like pregnancy complications or antibiotics, as risk factors for non-oesophageal eosinophilic gastrointestinal diseases (non-EoE EGIDs)​. Read more

Eosinophilic Disease Advocacy for Children and Transition care

The EOS Network participated in a significant paediatric gastroenterology event, advocating for better care for eosinophilic disease patients. We distributed information packs to healthcare professionals and established valuable connections, raising awareness and promoting a patient-centric approach. Read more

Impact of Dose Reduction of Topical Steroids on Adrenal Insufficiency in Paediatric Eosinophilic Esophagitis

The study shows adjusting a topical swallow steroid regimen can help manage adrenal insufficiency in children with Eosinophilic Oesophagitis EoE, but this may come at the expense of disease control. Read more

New Insights into Eosinophilic Esophagitis: The Role of Type II IL-4 Receptor

A study reveals the importance of IL-13 signalling in Eosinophilic Oesophagitis (EoE) and suggests potential new treatment approaches targeting the IL-4 receptor. Read more

Benralizumab Shows Reduce in Eosinophil Count: A Phase 2 Trial Report

Phase 2 trial shows benralizumab induces histological remission in 77% of eosinophilic gastritis patients, but further research on other immune pathways is needed Read more

Fluticasone Propionate Orally Disintegrating Tablet for Eosinophilic Esophagitis

Discover the efficacy of fluticasone oral disintegrating tablet in treating eosinophilic esophagitis (EoE) based on a randomised phase 2 controlled trial. Read more

Clinical Guidance for the Use of Dupilumab in Eosinophilic Oesophagitis: A Comprehensive Approach

The latest USA guidance on the use of dupilumab in EoE. Insights into when and how to consider dupilumab as a first-line or step-up therapy, shared decision-making approach and monitoring outcomes. Read more

Delayed EGID Diagnosis Can Impair Growth in Children

An Italian study has found that paediatric patients with Eosinophilic Gastrointestinal Diseases EGIDs were prone to be underweight. Symptoms associated with their EGIDs were impeding their weight gain but going undiagnosed. Read more

Oral Immunotherapy and Eosinophilic Esophagitis

Discover the latest findings on oral immunotherapy (OIT) for children with food allergies and its link to eosinophilic esophagitis (EoE). Learn about the study's methods, results, and implications for patient care. Read more